Copyright Reports & Markets. All rights reserved.

Global Cardiovascular Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Cardiovascular Drug Market Overview

      • 1.1 Product Overview and Scope of Cardiovascular Drug
      • 1.2 Cardiovascular Drug Segment by Type
        • 1.2.1 Global Cardiovascular Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 heparin
        • 1.2.3 Coumadin
        • 1.2.4 Sectral
        • 1.2.5 Zebeta
        • 1.2.6 Lopressor
        • 1.2.7 Toprol XL
        • 1.2.8 Norvasc
        • 1.2.9 Lotrel
      • 1.3 Cardiovascular Drug Segment by Application
        • 1.3.1 Cardiovascular Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Cardiovascular Drug Market by Region
        • 1.4.1 Global Cardiovascular Drug Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Cardiovascular Drug Market Size
        • 1.5.1 Global Cardiovascular Drug Revenue (2014-2025)
        • 1.5.2 Global Cardiovascular Drug Production (2014-2025)

      2 Global Cardiovascular Drug Market Competition by Manufacturers

      • 2.1 Global Cardiovascular Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Cardiovascular Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Cardiovascular Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Cardiovascular Drug Production Sites, Area Served, Product Types
      • 2.5 Cardiovascular Drug Market Competitive Situation and Trends
        • 2.5.1 Cardiovascular Drug Market Concentration Rate
        • 2.5.2 Cardiovascular Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Cardiovascular Drug Production Market Share by Regions

      • 3.1 Global Cardiovascular Drug Production Market Share by Regions
      • 3.2 Global Cardiovascular Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Cardiovascular Drug Production
        • 3.4.1 North America Cardiovascular Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Cardiovascular Drug Production
        • 3.5.1 Europe Cardiovascular Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Cardiovascular Drug Production (2014-2019)
        • 3.6.1 China Cardiovascular Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Cardiovascular Drug Production (2014-2019)
        • 3.7.1 Japan Cardiovascular Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Cardiovascular Drug Consumption by Regions

      • 4.1 Global Cardiovascular Drug Consumption by Regions
      • 4.2 North America Cardiovascular Drug Consumption (2014-2019)
      • 4.3 Europe Cardiovascular Drug Consumption (2014-2019)
      • 4.4 China Cardiovascular Drug Consumption (2014-2019)
      • 4.5 Japan Cardiovascular Drug Consumption (2014-2019)

      5 Global Cardiovascular Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Cardiovascular Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Cardiovascular Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Cardiovascular Drug Price by Type (2014-2019)
      • 5.4 Global Cardiovascular Drug Production Growth by Type (2014-2019)

      6 Global Cardiovascular Drug Market Analysis by Applications

      • 6.1 Global Cardiovascular Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Cardiovascular Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Cardiovascular Drug Business

      • 7.1 Amgen
        • 7.1.1 Amgen Cardiovascular Drug Production Sites and Area Served
        • 7.1.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.1.3 Amgen Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 AstraZeneca
        • 7.2.1 AstraZeneca Cardiovascular Drug Production Sites and Area Served
        • 7.2.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.2.3 AstraZeneca Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Bayer
        • 7.3.1 Bayer Cardiovascular Drug Production Sites and Area Served
        • 7.3.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.3.3 Bayer Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Bristol Myers Squibb and Pfizer
        • 7.4.1 Bristol Myers Squibb and Pfizer Cardiovascular Drug Production Sites and Area Served
        • 7.4.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.4.3 Bristol Myers Squibb and Pfizer Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Daiichi Sankyo
        • 7.5.1 Daiichi Sankyo Cardiovascular Drug Production Sites and Area Served
        • 7.5.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.5.3 Daiichi Sankyo Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Johnson & Johnson
        • 7.6.1 Johnson & Johnson Cardiovascular Drug Production Sites and Area Served
        • 7.6.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.6.3 Johnson & Johnson Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Merck & Co.
        • 7.7.1 Merck & Co. Cardiovascular Drug Production Sites and Area Served
        • 7.7.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.7.3 Merck & Co. Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Novartis
        • 7.8.1 Novartis Cardiovascular Drug Production Sites and Area Served
        • 7.8.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.8.3 Novartis Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Pfizer
        • 7.9.1 Pfizer Cardiovascular Drug Production Sites and Area Served
        • 7.9.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.9.3 Pfizer Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Portola
        • 7.10.1 Portola Cardiovascular Drug Production Sites and Area Served
        • 7.10.2 Cardiovascular Drug Product Introduction, Application and Specification
        • 7.10.3 Portola Cardiovascular Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Sanofi

      8 Cardiovascular Drug Manufacturing Cost Analysis

      • 8.1 Cardiovascular Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Cardiovascular Drug
      • 8.4 Cardiovascular Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Cardiovascular Drug Distributors List
      • 9.3 Cardiovascular Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Cardiovascular Drug Market Forecast

      • 11.1 Global Cardiovascular Drug Production, Revenue Forecast
        • 11.1.1 Global Cardiovascular Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Cardiovascular Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Cardiovascular Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Cardiovascular Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Cardiovascular Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Cardiovascular Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Cardiovascular Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Cardiovascular Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Cardiovascular Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Cardiovascular Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Cardiovascular Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Cardiovascular Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Cardiovascular Drug Consumption Forecast (2019-2025)
      • 11.4 Global Cardiovascular Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Cardiovascular Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Cardiovascular disease (CVD) is a major cause of death in the U.S. and rest of the world. These diseases are primarily related with heart and blood vessels disorders, such asischemic heart disease, dyslipidemia, stroke, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease and others. These disorders are mainly reported due to obesity, high cholesterol, smoking, excessi alcohol, and poor lifestyle.
        The hypertension segment recorded $64.9 billion in sales in 2009. By a large margin, hypertension is the largest segment within the cardiovascular market, driven by a large number of billion-dollar-plus therapies.

        The global Cardiovascular Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Cardiovascular Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiovascular Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Amgen
        AstraZeneca
        Bayer
        Bristol Myers Squibb and Pfizer
        Daiichi Sankyo
        Johnson & Johnson
        Merck & Co.
        Novartis
        Pfizer
        Portola
        Sanofi

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        heparin
        Coumadin
        Sectral
        Zebeta
        Lopressor
        Toprol XL
        Norvasc
        Lotrel

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now